U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals to revive patents for its sleep-disorder drug Hetlioz that were previously declared invalid in a dispute with generic drugmakers Teva and Apotex.
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Legal battle details, implications, and market impact."
US Supreme Court rejects Vanda's bid to revive patents on sleep disorder drug Hetlioz
The High Court has rebuffed Vanda’s bid to contest the May 2023 ruling from the U.S. Court of Appeals for the Federal Circuit roughly four months after the company appealed to the Supreme Court to review the decision, according to a SCOTUS order list published Monday.
Supreme Court Denies Vanda’s Petition in Hetlioz Patent Case Against Teva
The U.S. Supreme Court on Monday indicated that it will not hear Vanda Pharmaceuticals’ petition in its patent case against Teva Pharmaceuticals regarding the former’s sleep-wake disorder drug Hetlioz.
Supreme Court will not hear D.C. biotech's patent infringement appeal
Future drug sales at one D.C. biotech stand to decline after the Supreme Court rejected its request to review its patent infringement lawsuit against a pair of competitors.
US Supreme Court reportedly declines to hear Vanda patent case
The US Supreme Court has reportedly declined to hear Vanda Pharmaceuticals' (NASDAQ:VNDA) case regarding the invalidation of certain patents for its sleep-wake disorder drug Hetlioz. Vanda had appealed to the high court after a lower court ruled in 2022 that Vanda’s patents for the product were invalid,
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Vanda's petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug Application litigation against Teva Pharmaceuticals USA,
Vanda Season 1 Streaming: Watch & Stream Online via Hulu
Vanda Season 1 is a crime drama series. It follows the story of Vanda, a single mother who turns to the life of crime in order to fight against financial instability and keep her family’s needs afloat ...
Pharmaceutical Technology4d
Vanda Pharmaceuticals gets grant for use of melatonin agonist tasimelteon in treating circadian rhythms
Discover how Vanda Pharmaceuticals' patent revolutionizes circadian rhythm disorder treatment with tasimelteon, tailored to patients' beta-adrenergic receptor antagonist use.
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed ...
Retail investors pulled back dramatically on stock purchases in April, adding to market’s woes
Retail investors went on a tax-season buyers strike that helped exacerbate the stock-market selloff in early April, according ...
The Motley Fool2d
Vanda Pharmaceuticals (NASDAQ: VNDA)
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis ...
KFGO9d
Shareholder Capital asks Vanda Pharma’s board to reconsider Future Pak’s offer
Investment firm Shareholder Capital sent a letter to drugmaker Vanda Pharmaceuticals' board on Thursday asking it to reconsider Future Pak's takeover offer. On April 17, Vanda rejected contract ...
JD Supra11d
Vanda Strikes Out at the Supreme Court
Two weeks ago we discussed Vanda Pharmaceuticals’ ambitious cert petition asking the Supreme Court to discontinue the “reasonable expectation of success” standard for patent obviousness that for ...
Vanda King
Pop culture obsessives writing for the pop culture obsessed.